Insulet Q3 revenue $340.8M (+24% YoY) beat guidance; Omnipod 5 drives 42% US growth

INSULET CORP

2022-Q3 EPS reported -$0.18 revenue$935,600,000

Revenue $340.8M, +23.7% YoY (+28.5% constant currency), above guidance of 17-20% constant currency.
US Omnipod revenue $238.1M (+42.4% YoY) on record new customer starts; International Omnipod $88.0M (-5.5%, +8.9% CC).
Adjusted EPS $0.45; GAAP net loss $(0.08)/share includes $36.8M charge for voluntary Omnipod DASH PDM correction.
Adjusted gross margin 66.1% (excl. PDM charge); GAAP gross margin 55.3%, down 1,320 bps.
Received CE Mark for Omnipod 5; expanded US indication to age 2; new basal-only pod for type 2 diabetes planned for 510(k).

item 2.02 item 9.01

Key facts

Extracted from this filing and checked against the source text.

Earnings Releases SEC 8-K Item 2.02 confidence 1.0

INSULET CORP reported the three months ended September 30, 2022 results: revenue $340.8 million, net income Net loss of $5.2 million, or $(0.08) per diluted share, EPS $(0.08) per diluted share.

Period: the three months ended September 30, 2022
Revenue: $340.8 million
Net income: Net loss of $5.2 million, or $(0.08) per diluted share
EPS: $(0.08) per diluted share
Result: reported results

Exact text from the filing

Omnipod ® brand of products, today announced financial results for the three months ended September 30, 2022. Third Quarter Financial Highlights: • Third quarter 2022 revenue of $340.8 million, up 23.7%, or 28.5% in constant currency 1 , compared to $275.6 million in the prior year, exceeds the guidance range of 17% to 20% in constant currency ◦ Total Omnipod revenue

View on SEC.gov

Browse all earnings releases →

INSULET CORP filing history →

Source: SEC EDGAR

accession 0001145197-22-000059

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.